Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 32, 2024 - Issue 4
Submit an article Journal homepage
113
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Impact of Initial Management on Disease Evolution in Vogt–Koyanagi–Harada Syndrome: A Retrospective Cohort of 50 Patients

Alice Fauquiera Department of Internal Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, FranceView further author information
, MD,
Thomas Barbaa Department of Internal Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, FranceView further author information
, MD, PhD,
Arnaud Hota Department of Internal Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, FranceView further author information
, MD, PhD,
Pascal Sèveb Department of Internal Medicine, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, FranceView further author information
, MD, PhD,
Sandra Elbanyc Department of Ophthalmology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, FranceView further author information
, MD,
Philippe Blanched Department of Internal Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Université de Paris Cité, Paris, FranceView further author information
, MD,
Dominique Monnete Department of Ophthalmology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Université de Paris Cité, Paris, FranceView further author information
, MD, PhD,
Antoine Brézine Department of Ophthalmology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Université de Paris Cité, Paris, FranceORCID Iconhttps://orcid.org/0000-0001-8461-3119View further author information
, MD, PhDORCID Icon,
Benjamin Terrierd Department of Internal Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Université de Paris Cité, Paris, FranceView further author information
, MD, PhD &
Cécile-Audrey Durela Department of Internal Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, FranceCorrespondence[email protected]
View further author information
, MD show all
Pages 402-406 | Received 05 Jan 2023, Accepted 20 Apr 2023, Published online: 04 May 2023

References

  • Lavezzo MM, Sakata VM, Morita C, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11(1):1‑21. doi:10.1186/s13023-016-0412-4.
  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. mai, 2001;131(5):647‑52. doi:10.1016/S0002-9394(01)00925-4.
  • Jap A, Luu CD, Yeo I, Chee SP. Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease. Eye. 2008;22(2):240‑5. doi:10.1038/sj.eye.6702591.
  • Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D, Abu El-Asrar AM. Prognostic factors in Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27(2‑3):201‑10. doi:10.1007/s10792-007-9062-9.
  • Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001;131(5):599‑606. doi:10.1016/S0002-9394(01)00937-0.
  • Yang P, Ye Z, Du L, et al. Novel treatment regimen of Vogt–Koyanagi–Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. Curr Eye Res. 2018;43(2):254‑61. doi:10.1080/02713683.2017.1383444.
  • Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of ‘sunset glow fundus’ in initial-onset acute uveitis associated with Vogt–Koyanagi–Harada disease. Acta Ophthalmol. 2017;95(1):85‑90. doi:10.1111/aos.13189.
  • Couto C, Schlaen A, Frick M, et al. Adalimumab treatment in patients with Vogt–Koyanagi–Harada disease. Ocul Immunol Inflamm. 2018;26(3):485‑9. doi:10.1080/09273948.2016.1236969.
  • Cuchacovich M, Solanes F, Díaz G, et al. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2010;18(3):200‑7. doi:10.3109/09273941003587541.
  • Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013;91(6):486‑93. doi:10.1111/j.1755-3768.2013.2254.x.
  • Diallo K, Revuz S, Clavel-Refregiers G, et al. Vogt-Koyanagi-Harada disease: a retrospective and multicentric study of 41 patients. BMC Ophthalmol. October 7, 2020;20(1):395. doi:10.1186/s12886-020-01656-x.
  • Miyanaga M, Kawaguchi T, Shimizu K, Miyata K, Mochizuki M. Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27(2‑3):183‑8. doi:10.1007/s10792-007-9076-3.
  • Papasavvas I, Tugal-Tutkun I, Herbort CP. Vogt-Koyanagi-Harada is a curable autoimmune disease: early diagnosis and immediate dual steroidal and non-steroidal immunosuppression are crucial prerequisites. J Curr Ophthalmol. 2020;32(4):310‑4. doi:10.4103/JOCO.JOCO_190_20.
  • Urzua CA, Velasquez V, Sabat P, et al. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2015;93(6):e475‑80. doi:10.1111/aos.12648.
  • Nakayama M, Keino H, Watanabe T, Okada AA. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. British J Ophthalmol. 2019;103(2):274‑8. doi:10.1136/bjophthalmol-2017-311691.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.